Related Experiment Video
Updated: May 8, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Fecal microbiota transplantation and donor standardization
Casey Owens1, Elizabeth Broussard, Christina Surawicz
1Division of Gastroenterology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Trends in Microbiology
|September 10, 2013
Summary
Clostridium difficile diarrhea is a severe infection. Fecal microbiota transplantation is an alternative to antibiotics for recurrent cases, but requires standardization for patients and donors.
Area of Science:
- Microbiology
- Infectious Diseases
Background:
- Clostridium difficile infection (CDI) is a common and severe gastrointestinal illness.
- Standard antibiotic treatments are often ineffective for refractory or recurrent CDI cases.
Purpose of the Study:
- To highlight the challenges and need for standardization in fecal microbiota transplantation (FMT) for CDI.
Main Methods:
- Review of current treatment strategies for CDI.
- Analysis of FMT as an alternative therapy.
- Identification of key areas requiring standardization in FMT.
Main Results:
- Antibiotics show limited efficacy in treating persistent or recurring CDI.
- Fecal microbiota transplantation presents a viable alternative treatment option for CDI.
- Standardization protocols for both donors and recipients are crucial for successful FMT outcomes.
Conclusions:
- Fecal microbiota transplantation offers a promising alternative for managing refractory and recurrent Clostridium difficile infections.
- Establishing standardized procedures for donor screening and patient preparation is essential to optimize the safety and efficacy of FMT.
Related Concept Videos
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...